Exchange: NASDAQ·Updated 04:26 PM EDT

SLRX Salarius Pharmaceuticals Inc

$5.89
$0.045
(0.77%)
Today
Closed $5.89
$0.26
(4.41%)
After Hours
Reported EarningsMay 9
Mkt Cap$3.11M
Vol418.00

About SLRX

Decoy Therapeutics, Inc. operates as a preclinical-stage biotechnology company. It engages in leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company was founded by Frederick E. Pierce, Barbara Hibner, Peter Marschel, Michael Lipp, and Jodi Cooper in 2020 and is headquartered in Houston, TX.
55

Bullish Sentiment

How do you feel about SLRX?

Advertisement|Remove ads.